Dare Bioscience Stock Price Patterns
| DARE Stock | USD 1.44 -0.04 -2.70% |
Momentum
Sell Stretched
Oversold | Overbought |
This view relates Dare Bioscience's headline activity to recent price response context.
Headline and social attention around Dare Bioscience are summarized to support volatility context.
Dare Bioscience after-hype prediction price | $ 1.43 |
The sentiment view is a companion to forecasting, technical studies, analyst estimates, and earnings trends.
Cross-verify projections for Dare Bioscience using Dare Bioscience Basic Forecasting Models. The model view provides projection context.Experienced Dare Bioscience's investors use mean reversion as a complement to momentum analysis: momentum identifies the trend; mean reversion identifies when that trend has extended beyond sustainable levels.
After-Hype Price Density Analysis
This probability distribution for Dare Bioscience is built from Monte Carlo simulations that incorporate Dare Bioscience's historical volatility, mean reversion tendencies, and jump risk. The resulting distribution captures a broader range of Dare Bioscience outcomes than simple linear.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The boundaries derived from Dare Bioscience's historical news analysis represent the range within which Dare Bioscience's price has typically settled after comparable headline events. Dare Bioscience's after-hype downside and upside margins for the prediction period are 0.07 and 4.14, respectively. Outcomes outside these boundaries are less common but not rare for Dare Bioscience.
Current Value
The after-hype framework applied to Dare Bioscience assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Dare Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dare Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dare Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.71 | 2.71 | 0.00 | 0.00 | 0 Events | 0 Events | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.44 | 1.43 | 0.69 |
|
Hype Timeline
Dare Bioscience is currently traded for 1.44. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Dare is projected to decline in value after the next headline, with the price expected to drop to 1.43. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -0.69%, whereas the daily expected return is currently at -0.71%. The volatility of related hype on Dare Bioscience is about 0.0%, with the expected price after the next announcement by competition of 1.44. The company recorded a loss per share of 1.83. Dare Bioscience last dividend was issued on the 20th of July 2017. The company completed a 1:12 stock split on 1st of July 2024. Given the investment horizon of 90 days the next projected press release will be in a few days. Cross-verify projections for Dare Bioscience using Dare Bioscience Basic Forecasting Models. The model view provides projection context.Related Hype Analysis
Understanding Dare Bioscience's position within its competitive set helps investors assess whether news affecting a peer is a headwind or tailwind for Dare Bioscience. This distinction requires knowledge of the competitive dynamics specific to Dare Bioscience's industry.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FBLG | FibroBiologics Common Stock | 0.00 | 0 per month | 5.62 | 0.08 | 17.65 | -10.71 | 45.92 | |
| CTXR | Citius Pharmaceuticals | 0.00 | 0 per month | 5.49 | 0.01 | 10.81 | -7.79 | 27.98 | |
| LPTX | Leap Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AIMD | Ainos Inc | 0.00 | 0 per month | 0.00 | -0.08 | 10.33 | -9.20 | 38.73 | |
| ATHA | Athira Pharma | 0.00 | 0 per month | 4.15 | 0.14 | 9.87 | -8.06 | 72.52 | |
| ASBP | Aspire BioPharma | 0.00 | 0 per month | 0.00 | -0.15 | 11.34 | -16.05 | 66.08 | |
| ADTX | Aditxt Inc | 0.00 | 0 per month | 0.00 | -0.20 | 17.17 | -21.33 | 58.07 | |
| PALI | Palisade Bio | 0.00 | 0 per month | 5.42 | 0.05 | 11.18 | -7.73 | 31.35 | |
| ANL | Adlai Nortye Ltd | 0.00 | 0 per month | 4.42 | 0.24 | 21.67 | -6.06 | 102.66 | |
| HOTH | Hoth Therapeutics | 0.00 | 0 per month | 0.00 | 0.0042 | 7.00 | -4.55 | 20.14 |
Dare Bioscience Additional Predictive Modules
Most predictive techniques to examine Dare price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dare using various technical indicators. When you analyze Dare charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Dare Bioscience evaluates news tone, positioning, and narrative momentum. News flow can reinforce structural moves in the underlying exposure set. Dare Bioscience has a market cap of 19.95 M, ROE of -25.43%.
Macroaxis compiles Dare Bioscience metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Not all fields update in real time.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for Dare Stock analysis
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |